Transactions

Since our inception in August 2016 we have advised corporate clients and raised more than SEK 11 billion from global specialist investors, blue chip pension funds and renown mutual funds. Before taking on a fund-raising advisory assignment we perform extensive due diligence to make sure that the companies we work with are of such high quality that we can leverage our global network of sophisticated investors. We take pride in executing transactions to help allocating capital to promising new life-saving efforts.

Transactions
67
Raised for clients
SEK 11bn+
Companies
24
Advising since
2016
June 2026
SEK 77m
Rights issue & directed issue
IRLAB TherapeuticsPress release
April 2026
SEK 113m
Rights issue & directed issue
SEK 83m + SEK 30m
Xspray PharmaPress release
December 2025
SEK 71m
Rights issue & directed issue
SEK 42m + SEK 29m
BrainCoolPress release
October 2025
SEK 210m
Directed share & warrant issue
Intellego TechnologiesPress release
September 2025
SEK 161m
Rights issue & directed issue
SEK 130m + SEK 31m
Xspray PharmaPress release
August 2025
SEK 122m
Rights issue & directed issue
SEK 80m + SEK 42m
January 2025
SEK 55m
Directed issue & loan
SEK 35m + SEK 20m
December 2024
SEK 235m
Loan & rights issue
SEK 100m + SEK 135m
Xspray PharmaPress release
December 2020
SEK 130m
Directed issue
IRLAB TherapeuticsPress release
February 2020
SEK 140m
Directed issue & rights issue
Episurf MedicalPress release
December 2019
SEK 215m
Directed issue & rights issue
IRLAB TherapeuticsPress release
July 2019
SEK 300m
Directed issue & secondary sale
Calliditas TherapeuticsPress release
November 2018
SEK 675m
Directed issue & secondary sale
Hansa BiopharmaPress release
November 2017
SEK 545m
Directed issue & rights issue
Infant Bacterial TherapeuticsPress release
Rulla till toppen